Session |
Topic |
Speaker |
September 15 (09:00-11:00) |
Session 1
Community-associated MRSA infections |
Unique Evolution of CA-MRSA Clones |
Geoffrey Coombs |
CA-MRSA as a new nosocomial pathogen |
Doo-Ryeon Chung |
A vaccine for Staphylococcus aureus? |
Robert Daum |
Treatment options for CA-MRSA infections |
Ian Gould |
|
Session 2
Emerging viral infections and vaccines |
Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity |
Hyuk-Joon Kwon |
Virological and immunological responses in MERS patients |
Nam-Hyuk Cho |
Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do? |
Masayuki Saijo |
Infectious Diseases in the 21st Century: A Battle Plan for Survival |
Michael Osterholm |
|
Session 3
Colistin-resistant gram-negatives |
Colistin resistance in gram-negatives |
Po-Ren Hsueh |
Emergence of mcr-1 colistin resistance: a new story begins |
Eun-Jeong Yoon |
What to use in the clinical practice? |
Yohei Doi |
Colistin resistance: is it preventable? |
Anucha Apisarnthanarak |
September 15 (16:00-17:30) |
Session 4
Carbapenem-resistant Enterobacteriaceae |
Carbapenemases, from KPC to NDM to OXA-48: diverse enzymes in diverse clones |
David Livermore |
Diagnostic challenges in detecting carbapenem resistance |
Kyungwon Lee |
Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae |
Ami Neuberger |
|
Session 5
One world, one health |
One Health lessons from investigation emerging viruses of bat origin |
Linfa Wang |
One health approaches to zoonotic diseases and AMR |
Yong Ho Park |
One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man |
John Clemens |
|
Session 6
Pediatric mycoplasmal infections |
Mycoplasma pneumoniae Infection in Children |
Cheng-Hsun Chiu |
Macrolide-resistant Mycoplasma pneumoniae pneumonia in children |
Eun Hwa Choi |
Management of severe mycoplasma infection: role of antibiotics and steroid |
Nancy Henry |